Beyond Regulation: Four PFAS Pressures Pharmaceutical Manufacturers Can’t Ignore

Pharmaceutical manufacturers often know where they intentionally use PFAS, but far fewer can say where all the PFAS entering and leaving their facilities actually come from. In this blog, learn why PFAS exposure is a mass-balance challenge and what it takes to map it.

As research on emerging environmental contaminants accelerates, both regulators and industry need clear guidance on exposure limits, mitigation and testing. Read how ITRC (including members from Battelle) is helping states evaluate contaminants, review emerging environmental technologies and establish technical content using a shared scientific foundation.

For semiconductor manufacturers, the question is no longer whether PFAS will require greater attention—it’s how quickly companies can understand and manage their exposure. This blog explores why PFAS are essential to semiconductor fabrication, how regulatory and environmental pressures are evolving, and how manufacturers can begin planning their path forward.

On May 14 and 15, 2026, Battelle co-sponsored "Beyond Forever: Bridging Policy and Industry with PFAS Solutions," convening policymakers and industry experts at Capitol Hill. We sat down with Battelle's Amy Dindal and Jeff Rose to unpack this important conversation about PFAS policy and solutions.

The United States is racing to secure the critical minerals that power modern life. While much of the focus has been on opening new mines or securing supplies overseas, one of America’s most accessible domestic resources has been hiding in plain sight.